|
AY50443 |
1,3-oxazino(5',6':5,6)naphth(1,2-e)(1,3)oxazine, 2,3,4,8,9,10-hexahydro-3,9-bis(phenylmethyl)- |
58671-21-9 |
C28H26N2O2 |
422.5182 |
VIEW DETAILS > |
|
AA87876 |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isothiazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, [2S-(2α,5α,6β)]- (9CI) |
16188-11-7 |
C19H19ClN3NaO4S2 |
475.9446 |
VIEW DETAILS > |
|
AH40172 |
N-OLEOYL-DL-TRYPTOPHAN ETHYL ESTER, 97 |
71806-22-9 |
C31H48N2O3 |
496.7244 |
VIEW DETAILS > |
|
BD16584 |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, aluminum salt (3:1), [2S-(2α,5α,6β)]- |
37765-39-2 |
C19H17AlCl2N3O5S |
497.3079 |
VIEW DETAILS > |
|
AH31867 |
4-[[1,3-dihydro-6-methyl-4-benzylfuro[3,4-c]pyridin-7-yl]oxy]-N-(isopropyl)butylamine dihydrochloride |
68484-35-5 |
C22H32Cl2N2O2 |
427.4077 |
VIEW DETAILS > |
|
AC03546 |
2,3-Diphenyl-1-(3-(4-(2-pyridyl)-1-piperazinyl)propyl)-3-pyrazolin-5-one |
87939-27-3 |
C27H29N5O |
439.5521 |
VIEW DETAILS > |
|
BJ80843 |
Copanlisib impurity B |
2132943-81-6 |
C21H26N8O4 |
454.4823 |
VIEW DETAILS > |
|
AE89796 |
3-hydroxy-10,11-dihydroquinidine |
130061-81-3 |
C20H28N2O7S |
440.5105 |
VIEW DETAILS > |
|
BE22196 |
Methanesulfonamide, N-[7-[(5-chloro-2,4-difluorophenyl)methyl]-7,8-dihydro-9-hydroxy-8-oxo-6H-pyrrolo[3,4-g]quinolin-5-yl]-N-methyl- |
915409-66-4 |
C20H16ClF2N3O4S |
467.8735 |
VIEW DETAILS > |
|
AA89088 |
1,2-Benzenedicarboxylic acid, 1,2-bis[2-(2-butoxyethoxy)ethyl] ester |
16672-39-2 |
C24H38O8 |
454.5537 |
VIEW DETAILS > |